Cargando…
What is the quality of drug safety information for patients: An analysis of REMS educational materials
BACKGROUND: Poor‐quality patient drug information has been identified as a major cause of preventable medication errors in the United States. The US Food and Drug Administration (FDA) has the authority to require marketing authorization holders of medicinal products to implement risk evaluation and...
Autores principales: | Chan, Hilda W., Russell, Andrea M., Smith, Meredith Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646909/ https://www.ncbi.nlm.nih.gov/pubmed/30003610 http://dx.doi.org/10.1002/pds.4614 |
Ejemplares similares
-
An Asymmetrical Hypothesis for the NREM-REM Sleep Alternation—What Is the NREM-REM Cycle?
por: Le Bon, Olivier
Publicado: (2021) -
REM Sleep: An Unknown Indicator of Sleep Quality
por: Barbato, Giuseppe
Publicado: (2021) -
Local Aspects of Avian Non-REM and REM Sleep
por: Rattenborg, Niels C., et al.
Publicado: (2019) -
Regulation of REM and Non-REM Sleep by Periaqueductal GABAergic Neurons
por: Weber, Franz, et al.
Publicado: (2018) -
Assessing the role of REM13, REM34 and REM46 during the transition to the reproductive phase in Arabidopsis thaliana
por: Manrique, Silvia, et al.
Publicado: (2023)